{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
BrightSpring Health Services, Inc.
BrightSpring Health Services Hits New 52-Week High of $60.48
BrightSpring Health Services, Inc. has achieved a new 52-week high, reflecting its strong performance in the Pharmaceuticals & Biotechnology sector. The company has significantly outperformed the S&P 500, boasting impressive financial metrics, including substantial net profit growth and a solid operating cash flow, reinforcing its favorable market position.
BrightSpring Health Services Hits New 52-Week High of $59.65
BrightSpring Health Services, Inc. has achieved a new 52-week high, reflecting its strong performance in the Pharmaceuticals & Biotechnology sector. With a market capitalization of USD 7,558 million, the company has reported significant growth, including a net profit increase and impressive financial metrics, showcasing its solid financial health.
BrightSpring Health Services Hits New 52-Week High of $44.87
BrightSpring Health Services, Inc. has achieved a new 52-week high, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The company reported significant net profit growth and impressive operating cash flow, alongside a high interest coverage ratio and notable returns over the past year, highlighting its robust financial health.
BrightSpring Health Services, Inc. Announces Revision in Stock Evaluation Amid Mixed Market Indicators
BrightSpring Health Services, Inc. has recently experienced a stock price adjustment, currently at $40.13. The company has shown strong resilience over the past year, achieving a return of 108.47%, significantly outperforming the S&P 500. Various technical indicators present a mixed performance outlook for the stock.
BrightSpring Health Services: A Multibagger with 106.77% Return and 313.63% Net Profit Growth
BrightSpring Health Services, Inc. has recently undergone a revision in its score, reflecting its strong market position and impressive performance metrics. The stock has outperformed the S&P 500 significantly over the past year, showcasing robust financial health with substantial net profit growth and high institutional confidence.
Is BrightSpring Health Services, Inc. overvalued or undervalued?
As of October 17, 2025, BrightSpring Health Services, Inc. is considered undervalued with a P/E ratio of 37, an EV to EBITDA of 12.65, and a PEG ratio of 0.12, outperforming the S&P 500 with a year-to-date return of 74.57%.
BrightSpring Health Services, Inc. Experiences Revision in Stock Evaluation Amid Strong Performance Metrics
BrightSpring Health Services, Inc. has recently adjusted its valuation, showcasing a P/E ratio of 37 and a low PEG ratio of 0.12, indicating growth potential. The company has outperformed the S&P 500 significantly over the past year, reflecting a strong market presence and competitive position within the Pharmaceuticals & Biotechnology sector.
Is BrightSpring Health Services, Inc. overvalued or undervalued?
As of October 17, 2025, BrightSpring Health Services, Inc. is considered undervalued with a P/E ratio of 37, a PEG ratio of 0.12 indicating strong growth potential, and a year-to-date return of 74.57%, outperforming the S&P 500's 13.30%.
Is BrightSpring Health Services, Inc. overvalued or undervalued?
As of October 17, 2025, BrightSpring Health Services, Inc. is considered undervalued with an attractive valuation grade, supported by a P/E ratio of 37, a PEG ratio of 0.12, and strong performance, significantly outperforming the S&P 500.
BrightSpring Health Services Hits New 52-Week High of $31.95
BrightSpring Health Services, Inc. reached a new 52-week high of USD 31.95 on October 15, 2025, reflecting a notable growth rate of 174.22% over the past year. The company, with a market capitalization of USD 4,514 million, showcases strong financial metrics, including a P/E ratio of 37.00.
BrightSpring Health Services Hits New 52-Week High at $30.00
BrightSpring Health Services, Inc. achieved a new 52-week high of USD 30.00 on October 1, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen a significant stock price increase over the past year and maintains a solid asset base relative to its market valuation.
BrightSpring Health Services Hits New 52-Week High of $29.64
BrightSpring Health Services, Inc. achieved a new 52-week high of USD 29.64 on September 30, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. With a market cap of USD 4,514 million, the company shows notable growth metrics, including a P/E ratio of 37.00 and a debt-to-equity ratio of 1.43.
BrightSpring Health Services Hits Day High with 7.92% Surge in Stock Price
BrightSpring Health Services, Inc. has demonstrated notable performance, achieving a significant annual return and strong year-to-date results. The company reported impressive financial metrics, including high operating cash flow and profit growth, despite a slight decline in promoter confidence as stakeholders reduced their holdings.
Is BrightSpring Health Services, Inc. technically bullish or bearish?
As of September 3, 2025, BrightSpring Health Services, Inc. shows a bullish technical trend with strong momentum indicators, despite a mildly bearish weekly KST, and has significantly outperformed the S&P 500 over the past year.
Is BrightSpring Health Services, Inc. overvalued or undervalued?
As of August 5, 2025, BrightSpring Health Services, Inc. is considered undervalued with a favorable valuation grade shift, showing strong performance with a year-to-date return of 60.01% and a one-year return of 83.25%, alongside competitive P/E and EV to EBITDA ratios compared to its peers.
Is BrightSpring Health Services, Inc. overvalued or undervalued?
As of May 2, 2025, BrightSpring Health Services, Inc. is considered overvalued with a P/E ratio of 37 and an EV to EBITDA of 12.65, indicating a shift to an expensive valuation grade compared to industry peers, despite a strong year-to-date stock performance of 33.71%.
Is BrightSpring Health Services, Inc. technically bullish or bearish?
As of June 6, 2025, the technical trend is bullish with moderate strength, supported by bullish MACD, Bollinger Bands, and moving averages, though a mildly bearish signal from Dow Theory and lack of RSI and KST signals suggest caution.
What does BrightSpring Health Services, Inc. do?
BrightSpring Health Services, Inc. is a small-cap company in the Pharmaceuticals & Biotechnology industry, with recent net sales of $2.878 billion and a net profit of $9 million. Key metrics include a market cap of $3.75 billion, a P/E ratio of 37.00, and a debt-to-equity ratio of 1.50.
How big is BrightSpring Health Services, Inc.?
As of Jun 18, BrightSpring Health Services, Inc. has a market capitalization of $3.75 billion, with recent net sales of $11.57 billion and a net profit of $35.08 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
